Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Good to see some buying today

<< Previous

Bullboard Posts

Next >>

Comment by tylerreddickon Feb 15, 2024 8:33pm

139 Views

Post# 35883275

RE:RE:Good to see some buying today

If you have been involved in any other biotech stocks, you'd know that the pain SBM shareholders have gone through isn't unique, but more the norm. But you would also know that if/when a biotech stock actually gets to market, the rewards can be eye-watering.

And yeah, I know, it is all just blah-blah-blah until we get that news release.

<< Previous

Bullboard Posts

Next >>

These cold weather stocks are looking to heat up for winter